Tag: Avastin,EGFR,ESMO,European Lung Cancer Conference,NSCLC,Non-Small Cell Lung Cancer,Press Releases,Tarceva,Veristrat,biomarker,blood-based cancer test,cancer diagnostics,oncology,personalized medicine
-
VeriStrat® Outcomes Data in Lung Cancer to be Presented at IASLC/ESMO 2nd European Lung Cancer Conference
Biodesix today announced that results from the VeriStrat biomarker analysis of a Phase III clinical trial will be presented by David Carbone, M.D., Ph.D., Professor of Medicine and Cancer Biology, Vanderbilt University School of Medicine, on Friday, April 30th at the 2nd European Lung Cancer Conference to be held in Geneva. The purpose of the…